On December 18, 2025, Phibro Animal Health Corp announced that Jack C. Bendheim will resign as CEO on July 1, 2026, transitioning to Executive Chairman, while Dani Bendheim will succeed him as CEO. This leadership change reflects ongoing family involvement in the company.